Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and the immunologic effects of
supplementation with low-dose and high-dose cholecalciferol (vitamin D3) in patients with
multiple sclerosis.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins